Literature DB >> 8258710

Characterization of a C3 receptor on the envelope of Schistosoma mansoni.

E E Silva1, M W Clarke, R B Podesta.   

Abstract

The surface of the syncytial epithelium of the human parasite, Schistosoma mansoni, consists of an apical plasma membrane (APM) and an overlying envelope (En). The rapid turnover of these membranes is an adaptation to parasitism and is influenced by ambient signals emanating from the host's immune system. The third component of complement (C3) has been shown to stimulate the synthesis of the En via a C3-binding protein (C3bp) and a Ca(2+)-dependent signal transduction mechanism. Using ELISA the C3bp was found to be restricted to the En. In addition, cross-linking of iodinated C3 to En proteins with the homobifunctional noncleavable disuccinimidyl suberate reagent yielded a receptor-C3 complex in excess of 250 kDa, and SDS-PAGE analysis of solubilized En proteins that were radiolabeled and chromatographed on C3-Sepharose revealed a 130-kDa protein that specifically bound to the C3 beads. In further experiments, using a photoactivatable radiolabeled cross-linker, the Denny-Jaffe reagent, C3 transferred the radiolabel to a 130-kDa En protein. Metabolic labeling experiments have demonstrated that this C3bp is synthesized by the parasite and, more importantly, antibodies raised against the C3bp blocked En synthesis in vivo. Also, the surface localization of the C3bp was demonstrated using immunolabeling electron microscopy. The data presented herein strongly suggest that the 130-kDa schistosome En protein is a C3bp responsible for renewal of the En in response to C3 binding.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258710

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Workineh Torben; Mayeen U Alam; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; David W Carey; Darrick Carter; Steven G Reed; Afzal A Siddiqui
Journal:  Vaccine       Date:  2014-01-04       Impact factor: 3.641

2.  Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.

Authors:  Weidong Zhang; Gul Ahmad; Workineh Torben; Zahid Noor; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; Maria Chavez-Suarez; Ronald B Podesta; Ronald C Kennedy; Afzal A Siddiqui
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

3.  Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.

Authors:  Gul Ahmad; Weidong Zhang; Workineh Torben; Zahid Noor; Afzal A Siddiqui
Journal:  Int J Infect Dis       Date:  2010-07-13       Impact factor: 3.623

4.  Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Workineh Torben; Mayeen U Alam; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; David W Carey; Darrick Carter; Steven G Reed; Afzal A Siddiqui
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

Review 5.  Subversion of complement by hematophagous parasites.

Authors:  Hélène Schroeder; Patrick J Skelly; Peter F Zipfel; Bertrand Losson; Alain Vanderplasschen
Journal:  Dev Comp Immunol       Date:  2009       Impact factor: 3.636

6.  Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model.

Authors:  Gul Ahmad; Weidong Zhang; Workineh Torben; Raymond T Damian; Roman F Wolf; Gary L White; Maria Chavez-Suarez; Ronald C Kennedy; Afzal A Siddiqui
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

7.  Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine.

Authors:  Gul Ahmad; Weidong Zhang; Workineh Torben; Chad Haskins; Sue Diggs; Zahid Noor; Loc Le; Afzal A Siddiqui
Journal:  Parasitol Res       Date:  2009-10-07       Impact factor: 2.289

8.  Complement plays a minimal role in Sm-p80-mediated protection against Schistosoma mansoni.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Mayeen U Alam; Richard Winn; Workineh Torben; Loc Le; Kory A Tillery; Afzal A Siddiqui
Journal:  Hum Vaccin Immunother       Date:  2013-12-27       Impact factor: 3.452

9.  On the three-finger protein domain fold and CD59-like proteins in Schistosoma mansoni.

Authors:  Leonardo P Farias; Greice Krautz-Peterson; Cibele A Tararam; Bogar O Araujo-Montoya; Tatiana R Fraga; Henrique K Rofatto; Floriano P Silva; Lourdes Isaac; Akram A Da'dara; R Alan Wilson; Charles B Shoemaker; Luciana C C Leite
Journal:  PLoS Negl Trop Dis       Date:  2013-10-24

Review 10.  Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?

Authors:  Cristina Toscano Fonseca; Sergio Costa Oliveira; Clarice Carvalho Alves
Journal:  Front Immunol       Date:  2015-03-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.